Bharat Biotech recruits 23,000 volunteers for COVID-19 vaccine trials

Covaxin has been evaluated in approximately 1,000 subjects in Phase I and Phase II clinical trials.

from The Hindu - News https://ift.tt/3n9Qo48
Reactions